On the other hand, downregulation of miR-133a has been detected in asthma and its upregulation is able to ameliorate airway remodeling through PI3K/AKT/mTOR signaling pathways by targeting IGFR1 (insulin-like growth factor I receptor [31]. This evidence concerns the gene AKT1 and asthma.